Spinal Dynorphin and Bradykinin Receptors Maintain Inflammatory Hyperalgesia

Journal of Pain

Volumn 9, Issue 12, 2008, Pages 1096-1105

  Luo, Miaw Chyi ^a   Chen, Qingmin ^a   Ossipov, Michael H ^a   Rankin, David R ^a   Porreca, Frank ^a   Lai, Josephine ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

complete Freund's adjuvant; G protein coupled receptor; inflammation; nociceptors; pain; Spinal cord

Indexed keywords

ANTIBODY; BRADYKININ ANTAGONIST; BRADYKININ RECEPTOR; DYNORPHIN; FREUND ADJUVANT; PRODYNORPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPERALGESIA; HYPERSENSITIVITY; INFLAMMATION; LUMBAR SPINAL CORD; MALE; NONHUMAN; RAT; RECEPTOR BLOCKING;

ADJUVANTS, IMMUNOLOGIC; ANALYSIS OF VARIANCE; ANIMALS; BRADYKININ; DYNORPHINS; FREUND'S ADJUVANT; HYPERALGESIA; INFLAMMATION; INJECTIONS, SPINAL; KALLIDIN; KININOGENS; MALE; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, BRADYKININ; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD; TRITIUM; UP-REGULATION;

EID: 56349144213     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2008.06.005     Document Type: Article

References (53)

1. Abraham K.E., McGinty J.F., and Brewer K.L. The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury. Neuroscience 104 (2001) 863-874
2. Andreeva L., and Rang H.P. Effect of bradykinin and prostaglandins on the release of calcitonin gene-related peptide-like immunoreactivity from the rat spinal cord in vitro. Br J Pharmacol 108 (1993) 185-190
3. Burgess S.E., Gardell L.R., Ossipov M.H., Malan Jr. T.P., Vanderah T.W., Lai J., and Porreca F. Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. J Neurosci 22 (2002) 5129-5136
4. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53 (1994) 55-63
5. Chavkin C., James I.F., and Goldstein A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215 (1982) 413-415
6. Civelli O., Douglass J., Goldstein A., and Herbert E. Sequence and expression of the rat prodynorphin gene. Proc Natl Acad Sci U S A 82 (1985) 4291-4295
7. Draisci G., Kajander K.C., Dubner R., Bennett G.J., and Iadarola M.J. Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation. Brain Res 560 (1991) 186-192
8. Dray A., Bettaney J., Forster P., and Perkins M.N. Activation of a bradykinin receptor in peripheral nerve and spinal cord in the neonatal rat in vitro. Br J Pharmacol 95 (1988) 1008-1010
9. Faden A.I., and Jacobs T.P. Dynorphin-related peptides cause motor dysfunction in the rat through a nonopiate action. Br J Pharmacol 81 (1984) 271-276
10. Faden A.I., Molineaux C.J., Rosenberger J.G., Jacobs T.P., and Cox B.M. Increased dynorphin immunoreactivity in spinal cord after traumatic injury. Regul Pept 11 (1985) 35-41
11. Faden A.I. Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury. Ann Neurol 27 (1990) 67-74
12. Faden A.I. Dynorphin increases extracellular levels of excitatory amino acids in the brain through a nonopioid mechanism. J Neurosci 12 (1992) 425-429
13. Fox A., Wotherspoon G., McNair K., Hudson L., Patel S., Gentry C., and Winter J. Regulation and function of spinal and peripheral neuronal B1 bradykinin receptors in inflammatory mechanical hyperalgesia. Pain 104 (2003) 683-691
14. Friedman H.J., Jen M.F., Chang J.K., Lee N.M., and Loh H.H. Dynorphin: A possible modulatory peptide on morphine or beta-endorphin analgesia in mouse. Eur J Pharmacol 69 (1981) 357-360
15. Gold M.S., and Flake N.M. Inflammation-mediated hyperexcitability of sensory neurons. Neuro-Signals 14 (2005) 147-157
16. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
17. Iadarola M.J., Brady L.S., Draisci G., and Dubner R. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: Stimulus specificity, behavioral parameters and opioid receptor binding. Pain 35 (1988) 313-326
18. Ji R.R., and Woolf C.J. Neuronal plasticity and signal transduction in nociceptive neurons: Implications for the initiation and maintenance of pathological pain. Neurobiol Dis 8 (2001) 1-10
19. Ji R.R., Befort K., Brenner G.J., and Woolf C.J. ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregulation and contributes to persistent inflammatory pain hypersensitivity. J Neurosci 22 (2002) 478-485
20. Ji R.R., Samad T.A., Jin S.X., Schmoll R., and Woolf C.J. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36 (2002) 57-68
21. Kajander K.C., Sahara Y., Iadarola M.J., and Bennett G.J. Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy. Peptides 11 (1990) 719-728
22. Koetzner L., Hua X.Y., Lai J., Porreca F., and Yaksh T. Nonopioid actions of intrathecal dynorphin evoke spinal excitatory amino acid and prostaglandin E2 release mediated by cyclooxygenase-1 and -2. J Neurosci 24 (2004) 1451-1458
23. Kohno T., Wang H., Amaya F., Brenner G.J., Cheng J.K., Ji R.R., and Woolf C.J. Bradykinin enhances AMPA and NMDA receptor activity in spinal cord dorsal horn neurons by activating multiple kinases to produce pain hypersensitivity. J Neurosci 28 (2008) 4533-4540
24. Lai J., Luo M.C., Chen Q., Ma S., Gardell L.R., Ossipov M.H., and Porreca F. Dynorphin A activates bradykinin receptors to maintain neuropathic pain. Nat Neurosci 9 (2006) 1534-1540
25. Laneuville O., Reader T.A., and Couture R. Intrathecal bradykinin acts presynaptically on spinal noradrenergic terminals to produce antinociception in the rat. Eur J Pharmacol 159 (1989) 273-283
26. Long J.B., Rigamonti D.D., Oleshansky M.A., Wingfield C.P., and Martinez-Arizala A. Dynorphin A-induced rat spinal cord injury: Evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury. J Pharmacol Exp Ther 269 (1994) 358-366
27. Malan T.P., Ossipov M.H., Gardell L.R., Ibrahim M., Bian D., Lai J., and Porreca F. Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats. Pain 86 (2000) 185-194
28. Noguchi K., Kowalski K., Traub R., Solodkin A., Iadarola M.J., and Ruda M.A. Dynorphin expression and Fos-like immunoreactivity following inflammation induced hyperalgesia are colocalized in spinal cord neurons. Brain Res 10 (1991) 227-233
29. Peters C.M., Lindsay T.H., Pomonis J.D., Luger N.M., Ghilardi J.R., Sevcik M.A., and Mantyh P.W. Endothelin and the tumorigenic component of bone cancer pain. Neuroscience 126 (2004) 1043-1052
30. Porreca F., Burgess S.E., Gardell L.R., Vanderah T.W., Malan Jr. T.P., Ossipov M.H., Lappi D.A., and Lai J. Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor. J Neurosci 21 (2001) 5281-5288
31. Rossier J. Opioid peptides have found their roots. Nature 298 (1982) 221-222
32. Ruda M.A., Iadarola M.J., Cohen L.V., and Young III W.S. In situ hybridization histochemistry and immunocytochemistry reveal an increase in spinal dynorphin biosynthesis in a rat model of peripheral inflammation and hyperalgesia. Proc Natl Acad Sci U S A 85 (1988) 622-626
33. Skilling S.R., Sun X., Kurtz H.J., and Larson A.A. Selective potentiation of NMDA-induced activity and release of excitatory amino acids by dynorphin: Possible roles in paralysis and neurotoxicity. Brain Res 575 (1992) 272-278
34. Sot U., Misterek K., Gumulka S.W., and Dorociak A. Intrathecal bradykinin administration: Opposite effects on nociceptive transmission. Pharmacology 66 (2002) 76-80
35. Stevens C.W., and Yaksh T.L. Dynorphin A and related peptides administered intrathecally in the rat: A search for putative kappa opiate receptor activity. J Pharmacol Exp Ther 238 (1986) 833-838
36. Suzuki R., Morcuende S., Webber M., Hunt S.P., and Dickenson A.H. Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nat Neurosci 5 (2002) 1319-1326
37. Tachibana T., Miki K., Fukuoka T., Arakawa A., Taniguchi M., Maruo S., and Noguchi K. Dynorphin mRNA expression in dorsal horn neurons after traumatic spinal cord injury: Temporal and spatial analysis using in situ hybridization. J Neurotrauma 15 (1998) 485-494
38. Terayama R., Dubner R., and Ren K. The roles of NMDA receptor activation and nucleus reticularis gigantocellularis in the time-dependent changes in descending inhibition after inflammation. Pain 97 (2002) 171-181
39. Vanderah T.W., Laughlin T., Lashbrook J.M., Nichols M.L., Wilcox G.L., Ossipov M.H., Malan Jr. T.P., and Porreca F. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: Blockade by MK-801 but not naloxone. Pain 68 (1996) 275-281
40. Vanderah T.W., Gardell L.R., Burgess S.E., Ibrahim M., Dogrul A., Zhong C.M., Zhang E.T., Malan Jr. T.P., Ossipov M.H., Lai J., and Porreca F. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci 20 (2000) 7074-7079
41. Vanderah T.W., Suenaga N.M., Ossipov M.H., Malan Jr. T.P., Lai J., and Porreca F. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci 21 (2001) 279-286
42. Vera-Portocarrero L.P., Xie J.Y., Kowal J., Ossipov M.H., King T., and Porreca F. Descending facilitation from the rostral ventromedial medulla maintains visceral pain in rats with experimental pancreatitis. Gastroenterology 130 (2006) 2155-2164
43. Vera-Portocarrero L.P., Zhang E.T., Ossipov M.H., Xie J.Y., King T., Lai J., and Porreca F. Descending facilitation from the rostral ventromedial medulla maintains nerve injury-induced central sensitization. Neuroscience 140 (2006) 1311-1320
44. Wagner R., and Deleo J.A. Pre-emptive dynorphin and N-methyl-D-aspartate glutamate receptor antagonism alters spinal immunocytochemistry but not allodynia following complete peripheral nerve injury. Neuroscience 72 (1996) 527-534
45. Walker J.M., Moises H.C., Coy D.H., Young E.A., Watson S.J., and Akil H. Dynorphin (1-17): Lack of analgesia but evidence for nonopiate electrophysiological and motor effects. Life Sci 31 (1982) 1821-1824
46. Wang H., Kohno T., Amaya F., Brenner G.J., Ito N., Allchorne A., Ji R.R., and Woolf C.J. Bradykinin produces pain hypersensitivity by potentiating spinal cord glutamatergic synaptic transmission. J Neurosci 25 (2005) 7986-7992
47. Wang Z., Gardell L.R., Ossipov M.H., Vanderah T.W., Brennan M.B., Hochgeschwender U., Hruby V.J., Malan Jr. T.P., Lai J., and Porreca F. Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci 21 (2001) 1779-1786
48. Weihe E., Millan M.J., Hollt V., Nohr D., and Herz A. Induction of the gene encoding pro-dynorphin by experimentally induced arthritis enhances staining for dynorphin in the spinal cord of rats. Neuroscience 31 (1989) 77-95
49. Winkler T., Sharma H.S., Gordh T., Badgaiyan R.D., Stalberg E., and Westman J. Topical application of dynorphin A (1-17) antiserum attenuates trauma induced alterations in spinal cord evoked potentials, microvascular permeability disturbances, edema formation and cell injury: An experimental study in the rat using electrophysiological and morphological approaches. Amino Acids 23 (2002) 273-281
50. Xie J.Y., Herman D.S., Stiller C.O., Gardell L.R., Ossipov M.H., Lai J., Porreca F., and Vanderah T.W. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J Neurosci 25 (2005) 409-416
51. Xu M., Petraschka M., McLaughlin J.P., Westenbroek R.E., Caron M.G., Lefkowitz R.J., Czyzyk T.A., Pintar J.E., Terman G.W., and Chavkin C. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance. J Neurosci 24 (2004) 4576-4584
52. Yaksh T.L., and Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 17 (1976) 1031-1036
53. Yang C.M., Tsai Y.J., Pan S.L., Wu W.B., Wang C.C., Lee Y.S., Lin C.C., Huang S.C., and Chiu C.T. Pharmacological and functional characterization of bradykinin receptors in rat cultured vascular smooth muscle cells. Cell Signal 11 (1999) 853-862